Chemotherapy-induced diffuse melanonychia.
Hsu
K-F
KF
Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei,Taiwan, Republic of China.
Yang
M-H
MH
Yu
J-C
JC
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy; D003116:Color; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D015251:Epirubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced*
D003561:Cytarabine; D015251:Epirubicin; D003520:Cyclophosphamide